Generalized Lipodystrophy
Also known as: Generalised Lipodystrophy / Total lipodystrophy / Congenital generalized lipodystrophy / Congenital lipodystrophy / Lipodystrophy congenital / Congenital generalised lipodystrophy / Lawrence-Seip syndrome / Congenital lipoatrophic diabetes / Acquired generalized lipodystrophy (disorder) / Lipodystrophy, Congenital Generalized / Berardinelli-Seip syndrome / Congenital total lipodystrophy (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB09046 | Metreleptin | A leptin analogue used as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients various forms of lipodystrophy. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB09046 | Metreleptin | Leptin receptor | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB16673 | Mibavademab | 2 | Active Not Recruiting | 1 |
DB09046 | Metreleptin | 2 / 3 | Completed | 1 |
DB09046 | Metreleptin | 4 | Active Not Recruiting | 1 |